Notify me when Rosalind Advisors, Inc. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | DELCATH SYSTEMS, INC. | 9.9% | $80.1M | $180K | 6.67M | +0.23% | Rosalind Advisors, Inc. | May 5, 2025 |
| NSPR | InspireMD, Inc. | Common Shares | 9.9% | $26.7M | 11M | 0% | Rosalind Advisors, Inc. | Aug 1, 2025 | |
| PYPD | PolyPid Ltd. | Common Shares | 9.9% | $19M | -$189K | 5.71M | -0.99% | Rosalind Advisors, Inc. | Sep 30, 2025 |
| BFRI | Biofrontera Inc. | Common Shares | 9.9% | $16.4M | $2.29M | 16.8M | +16.2% | Rosalind Advisors, Inc. | Oct 27, 2025 |
| TLPH | TALPHERA, INC. | Common Shares | 9.9% | $12.5M | $5.64M | 14M | +82.6% | Rosalind Advisors, Inc. | Sep 30, 2025 |
| MYO | MYOMO, INC. | Common Shares | 9.9% | $6.74M | $174K | 7.55M | +2.65% | Rosalind Advisors, Inc. | Sep 30, 2025 |
| CLRB | Cellectar Biosciences, Inc. | Common Shares | 9.9% | $3.06M | 7.47M | Rosalind Advisors, Inc. | Dec 31, 2024 | ||
| KPRX | KIORA PHARMACEUTICALS INC | Common Shares | 9.9% | 465K | -35% | Rosalind Advisors, Inc. | Jun 30, 2025 | ||
| FENC | FENNEC PHARMACEUTICALS INC. | Common Shares | 7.5% | $19.4M | 2.08M | Rosalind Advisors, Inc. | Sep 30, 2025 | ||
| MDWD | MediWound Ltd. | Common Shares | 7% | 912K | +60% | Rosalind Advisors, Inc. | Sep 30, 2025 | ||
| TRVI | Trevi Therapeutics, Inc. | Common Shares | 1.2% | $6.43M | 1.06M | Rosalind Advisors, Inc. | Feb 13, 2025 | ||
| OPTN | OptiNose, Inc. | Common Shares | 0% | $0 | -$3.13M | 0 | -100% | Rosalind Advisors, Inc. | Jun 30, 2025 |
| SPRB | SPRUCE BIOSCIENCES, INC. | Common shares | 0% | $0 | 0 | Rosalind Advisors, Inc. | Dec 31, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|